Literature DB >> 16741172

Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population.

Allison G Hays1, Ralph L Sacco, Tanja Rundek, Robert R Sciacca, Zhezhen Jin, Rui Liu, Shunichi Homma, Marco R Di Tullio.   

Abstract

BACKGROUND AND
PURPOSE: Left ventricular dysfunction (LVD) is associated with cardiovascular mortality. Its association with ischemic stroke has been mainly documented after myocardial infarction. The stroke risk associated with LVD, especially of mild degree, in the general population is unclear. The purpose of this study was to evaluate the relationship between LVD and ischemic stroke in a multiethnic cohort.
METHODS: LV systolic function was assessed by transthoracic 2-dimensional echocardiography in a subset of subjects from the Northern Manhattan Study (NOMAS), 270 patients with first ischemic stroke and 288 age-, gender- and race-matched community controls. LV ejection fraction was measured by a simplified cylinder-hemiellipsoid formula, and categorized as normal (>50%), mildly (41% to 50%), moderately (31% to 40%) or severely (< or =30%) decreased. The association between impaired ejection fraction and ischemic stroke was evaluated by logistic regression analysis after adjustment for established stroke risk factors.
RESULTS: LVD of any degree was more frequent in stroke patients (24.1%) than in controls (4.9%; P<0.0001), as was moderate/severe LVD (13.3% versus 2.4%; P<0.001). A decreased ejection fraction was associated with ischemic stroke even after adjusting for other stroke risk factors. The adjusted odds ratio for any degree of LVD was 3.92 (95% CI, 1.93 to 7.97). The adjusted odds ratio for mild LVD was 3.96 (95% CI, 1.56 to 10.01) and for moderate/severe LVD 3.88 (95% CI, 1.45 to 10.39). The association between LVD of any degree and stroke was present in all age, gender and race-ethnicity subgroups.
CONCLUSIONS: LVD, even of mild degree, is independently associated with an increased risk of ischemic stroke. The assessment of LV function should be considered in the assessment of the stroke risk.

Entities:  

Mesh:

Year:  2006        PMID: 16741172      PMCID: PMC2677017          DOI: 10.1161/01.STR.0000227121.34717.40

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  21 in total

1.  Infarcts of undetermined cause: the NINCDS Stroke Data Bank.

Authors:  R L Sacco; J H Ellenberg; J P Mohr; T K Tatemichi; D B Hier; T R Price; P A Wolf
Journal:  Ann Neurol       Date:  1989-04       Impact factor: 10.422

2.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

3.  Influence of age on the prognostic importance of left ventricular dysfunction and congestive heart failure on long-term survival after acute myocardial infarction. TRACE Study Group.

Authors:  L Køber; C Torp-Pedersen; M Ottesen; H Burchardt; E Korup; K Lyngborg
Journal:  Am J Cardiol       Date:  1996-07-15       Impact factor: 2.778

4.  The prevalence of treatable left ventricular systolic dysfunction in patients who present with noncardiac vascular episodes: a case-control study.

Authors:  Robert Kelly; Anthony Staines; Ron MacWalter; Peter Stonebridge; Hugh Tunstall-Pedoe; Allan D Struthers
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

Review 5.  Stroke in patients with heart failure and reduced left ventricular ejection fraction.

Authors:  P M Pullicino; J L Halperin; J L Thompson
Journal:  Neurology       Date:  2000-01-25       Impact factor: 9.910

6.  Natural history of asymptomatic left ventricular systolic dysfunction in the community.

Authors:  Thomas J Wang; Jane C Evans; Emelia J Benjamin; Daniel Levy; Elizabeth C LeRoy; Ramachandran S Vasan
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

Review 7.  The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening.

Authors:  Thomas J Wang; Daniel Levy; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Ann Intern Med       Date:  2003-06-03       Impact factor: 25.391

8.  Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Arch Intern Med       Date:  1987-09

9.  Risk stratification and survival after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1983-08-11       Impact factor: 91.245

10.  Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy.

Authors:  Robert N Doughty; Gillian A Whalley; Helen A Walsh; Greg D Gamble; José López-Sendón; Norman Sharpe
Journal:  Circulation       Date:  2004-01-05       Impact factor: 29.690

View more
  40 in total

Review 1.  Prevention of cardioembolic stroke.

Authors:  William David Freeman; Maria I Aguilar
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

2.  Use of novel oral anticoagulants in patients with heart failure.

Authors:  Eduard Shantsila; Gregory Y H Lip
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-02

3.  Echocardiographic findings in ischemic stroke patients with obstructive sleep apnea.

Authors:  Anna Svatikova; Renuka Jain; Ronald D Chervin; Peter G Hagan; Devin L Brown
Journal:  Sleep Med       Date:  2011-08       Impact factor: 3.492

4.  Race-ethnic differences in subclinical left ventricular systolic dysfunction by global longitudinal strain: A community-based cohort study.

Authors:  Cesare Russo; Zhezhen Jin; Shunichi Homma; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio
Journal:  Am Heart J       Date:  2015-02-21       Impact factor: 4.749

5.  Subclinical left ventricular dysfunction and silent cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study.

Authors:  Cesare Russo; Zhezhen Jin; Shunichi Homma; Mitchell S V Elkind; Tatjana Rundek; Mitsuhiro Yoshita; Charles DeCarli; Clinton B Wright; Ralph L Sacco; Marco R Di Tullio
Journal:  Circulation       Date:  2013-07-31       Impact factor: 29.690

6.  Thromboembolic risk in the patient with heart failure.

Authors:  Liviu Klein; John B O'connell
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

Review 7.  Safety and efficacy of new anticoagulants in patients with heart failure.

Authors:  Ron Pisters; Gregory Y H Lip
Journal:  Curr Heart Fail Rep       Date:  2013-03

8.  Blood pressure and stroke in heart failure in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  Patrick M Pullicino; Leslie A McClure; Virginia G Wadley; Ali Ahmed; Virginia J Howard; George Howard; Monika M Safford
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

9.  Heart failure in acute ischemic stroke.

Authors:  Angel Ois; Meritxell Gomis; Elisa Cuadrado-Godia; Jordi Jiménez-Conde; Ana Rodríguez-Campello; Jordi Bruguera; Lluis Molina; Josep Comin; Jaume Roquer
Journal:  J Neurol       Date:  2008-03-19       Impact factor: 4.849

10.  A single-center experience with intracardiac thrombosis in children with dilated cardiomyopathy.

Authors:  Soo-Han Choi; Soo In Jeong; Ji-Hyuk Yang; I-Seok Kang; Tae-Gook Jun; Heung-Jae Lee; June Huh
Journal:  Pediatr Cardiol       Date:  2010-02       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.